Showing results (111-120 of 330) with videos related to

Sort By:
Pageof 33
JACC. Cardiooncology|October 19, 2020
Doxorubicin-Induced Oxidative Stress and Endothelial Dysfunction in Conduit Arteries Is Prevented by Mitochondrial-Specific Antioxidant TreatmentZachary S Clayton, Vienna E Brunt, David A Hutton, et al.
JACC. Cardiooncology|December 7, 2020
Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac AmyloidosisKathleen W Zhang, Jennifer Miao, Joshua D Mitchell, et al.
JACC. Cardiooncology|January 6, 2022
Detection of Subclinical Cardiovascular Disease by Cardiovascular Magnetic Resonance in Lymphoma SurvivorsNikki van der Velde, Cécile P M Janus, Daniel J Bowen, et al.
JACC. Cardiooncology|January 6, 2022
Cardiovascular Burden and Adverse Events in Patients With Esophageal Cancer Treated With Chemoradiation for Curative IntentMette Marie A Søndergaard, Marianne Nordsmark, Kirsten M Nielsen, et al.
JACC. Cardiooncology|January 6, 2022
Risk for Myocardial Infarction Following 5-Fluorouracil Treatment in Patients With Gastrointestinal Cancer: A Nationwide Registry-Based StudyJan Walter Dhillon Shanmuganathan, Kristian Kragholm, Bhupendar Tayal, et al.
JACC. Cardiooncology|November 8, 2021
Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot StudyAayush Kumar Singal, Raghav Bansal, Avinainder Singh, et al.
JACC. Cardiooncology|June 13, 2020
The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular ToxicityLori Minasian, Eileen Dimond, Myrtle Davis, et al.
JACC. Cardiooncology|August 16, 2021
Predictive Value of the Platelet-to-Lymphocyte Ratio in Cancer Patients Undergoing Transcatheter Aortic Valve ReplacementNoriaki Tabata, Baravan Al-Kassou, Atsushi Sugiura, et al.
JACC. Cardiooncology|August 16, 2021
Proceedings From the Global Cardio-Oncology Summit: The Top 10 Priorities to Actualize for CardioOncologyDaniel J Lenihan, Michael G Fradley, Susan Dent, et al.
JACC. Cardiooncology|August 16, 2021
Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid CardiomyopathyKent Y Feng, Rahul S Loungani, Vishal N Rao, et al.
Pageof 33